Zai Lab opens books for $106m US listing
Chinese biotech firm Zai Lab has launched bookbuilding for a $105.9m IPO of American Depository Shares (ADS), and is counting on US investors favouring start-ups to support the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: